Dr. Sadeghi earned his medical degree from Tehran University. He then earned his Master's in Health Information Sciences from University of Texas, followed by a residency in general surgery and internal medicine. Dr. Sadeghi received his PhD in Public Health, immediately followed by a Hematology/Oncology Fellowship at Taussig Cancer Institute.
Dr. Sadeghi currently serves as the USC IRB Vice Chair, and as a California Cancer Consortium Distinguished Faculty Member. He also has a patent for Automated Medical Decision Making Utilizing Bayesian Network Domain Modeling.
. View in: PubMed
Comparative effectiveness of screening strategies for lynch syndrome. J Natl Cancer Inst. 2015 Apr; 107(4). View in: PubMed
Timeliness of Adjuvant Chemotherapy for Stage III Adenocarcinoma of the Colon: A Measure of Quality of Care. Clin Colorectal Cancer. 2013 Dec; 12(4):275-9. View in: PubMed
Tivozanib in the treatment of renal cell carcinoma. Biologics. 2013; 7:139-48. View in: PubMed
Current status of targeted therapy in metastatic transitional cell carcinoma of the bladder. Semin Oncol. 2012 Oct; 39(5):608-14. View in: PubMed
Screening for Lynch syndrome in the general population-letter. Cancer Prev Res (Phila). 2011 Mar; 4(3):471; author reply 472. View in: PubMed
A Bayesian model for triage decision support. Int J Med Inform. 2006 May; 75(5):403-11. View in: PubMed
Ontology Driven Construction of a Knowledgebase for Bayesian Decision Models Based on UMLS. Stud Health Technol Inform. 2005; 116:223-8. View in: PubMed
Determinants of operative mortality following primary coronary artery bypass surgery. Eur J Cardiothorac Surg. 2002 Feb; 21(2):187-92. View in: PubMed
Self-administered decision support tool for triage: results of a retrospective study. Stud Health Technol Inform. 2002; 85:45-51. View in: PubMed